DAFTAR PUSTAKA
Ahuja, S.D., Ashkin, D., and Avendano, M. (2012). Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. Halaman 9.
Albert, H., Bwanga, F., and Mukkada, S. (2010). Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda. BMC Infectious Disease. 10(41).
Banada, P.P., Sivasubramani, S.K., and Blakemore, R. (2010). Contaiment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicabilityto point-of-care settings. J. Clin. Microbiol. 48:3551-3557.
Calligaro, G.L., Moodley, L., Symons, G., and Dheda, K. (2014). The medical and surgical treatment of drug resistant tuberculosis. J Thorac Dis. 6(3):186-195.
Caminero, J.A. (2013). Justification for the guidelines. Dalam: Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis.
International Union Against Tuberculosis and Lung Disease. Hal 1-6.
Castan P, Pablo A, and Romero A. (2014). Point of care system for detection of Mycobacterium tuberculosis and rifampin resistance in sputum samples. J Clin Microbio;52(2):502-507.
Chiang, C.Y. (2013). Basic concepts and definitions of drug resistance in tuberculosis Dalam Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis. International Union Against Tuberculosis and Lung Disease. Halaman 13-25.
Coovadia, YM., Mahomed, S., Pillay, M., Werner, L., and Mlisana, K. (2013). Rifampicin Mono-Resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: A Significant Phenomenon in a high prevalence TB-HIV region. PLoS One;8(11).
Da Silva, P.E.A., and Palomino, J.C. (2011). Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs.
Direktorat Jenderal Bina Upaya Kesehatan. (2012) .Petunjuk teknis pemeriksaan biakan, identifikasi, dan uji kepekaan Mycobacterium tuberculosis pada media padat. Kementerian Kesehatan Republik Indonesia. 2012. Available at:
http://perpustakaan.depkes.go.id:8180/bitstream//123456789/1796/2/BK20 12-401.pdf. Accesed: 19 September 2015.
Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan (Ditjen PP dan PL). (2014). Petunjuk teknis manajemen terpadu pengendalian tuberkulosis resistan obat. Kementerian Kesehatan Republik Indonesia. 1-107.
Enarson, D.A., and Harries, A.D. (2013). Historical background and global epidemiology of Mycobacterium tuberculosis resistance. Dalam: Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis. International Union Against Tuberculosis and Lung Disease. Halaman 7-12.
Gandasoebrata, R. (1992). Penuntun Laboratorium Klinik. Penerbit Dian Rakyat, Bandung. Halaman 176
Hakeem, A., Hussain, M.S., and Imran Sarwar, M.I. (2013). GeneXpert MTB/RIF- a novel diagnostic tool for tuberculosis in pulmonary samples.
IOSR Journal of Dental and Medical Sciences. 8:1-3.
Hanafi, A.R., dan Prasenohadi. (2010). Mekanisme dan diagnosis multidrug resistant tuberculosis. PPTI, 2010. Available at:
www.ppti.info/2010/07/mekanisme-dan-diagnosis-multidrug.html.
Ioannidis, P., Papaventsis, D., and Karabela, S. (2011). Cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampisisn resistance identification in patiens with substantial clinical indications of tuberculosis and smear-negative microscopy results. J. Clin. Microbiol. 49(8):3068-3070.
Li, J., Xin, J., Zhang, L., Jiang, L., Cao, H., and Li, L. (2012) Rapid detection of rpoB in rifampin resistant M. tuberculosis from sputum samples by denaturing gradient gel electrophoresis. Int J Med Sci. 9(2):148-156.
Liang, L., Wu, Q., and Gao, L. (2012). Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China. Thorax. Halaman 67.
Lingala, M.A.L., Aparna S., Suman J., K.V.S.M. Rao and P.V. Ranganadha R. (2010). Clinical and Geographical Profiles of rpoB Gene Mutations in
Mycobacterium tuberculosis Isolates from Hyderabad and Koraput in India. Journal of Microbiology and Antimicrobials, 2(2) : 13-18.
Lisdawati, V., I. Parwati., Sudarmon, TM., Sudiro, R., R. Ramadhany., N. Puspandari., et al. (2010). Studi Pemetaan Awal Dna Mycobacterium tuberculosis complex Secara Spoligotyping Pada Hasil Isolasi Dahak Pasien Tuberkulosis Paru dari 10 Kota Propinsi (Bagian I). Buletin Penelitian Kesehatan. 38(4): 169-185
Low, S., Ang, L.W., and Cutter, J. (2009). Mortality among tuberculosis patients on treatment in Singapore. Int J Tuberc Lung Dis. 13:328-334.
Menzies, D., Benedetti, A., and Paydar, A. (2009). Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and metaanalysis. PLoS Med. 6(9).
Micheletti, V.C.D., Moreira, J.S., Ribeiro, M.O., Kritski, A.L., and Braga, J.U. (2014). Drug-resistant tuberculosis in subjects included in the second national survey on antituberculosis drug resistance in Porto Alegre, Brazil.
J Bras Pneumol. 40(2):155-163.
Migliori, G.B., D’Arcy Richardson, M., Sotgiu, G., and Lange, C. (2009). Multidrug-resistant and extensively drug resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control. Clin Chest Med. 30:637-665.
Minion, J., Gallant, V., and Wolfe, J. (2013). Multidrug and extensively drug-resistant tuberculosis in Canada 1997–2008: demographic and disease characteristics. PLoS One. Page 8.
Nathanson, E., Nunn, P., and Uplekar, M. (2010). MDR tuberculosis — critical steps for prevention and control. N Engl J Med. 363:1050-1058.
Nawas, A. (2010). Penatalaksanaan TB MDR dan strategi DOTS plus. Jurnal Tuberkulosis Indonesia. 7:1-7.
Nghiem, N.M. (2011). Molecular Characteristic of Rifampisin and Isonizid Resistant Mycobacterium tuberculosis Strains Isolated in Vietnam.
Journal of Clinical Microbiology. Halaman 598-601.
Nofizar, D., Nawas, A., dan Burhan, E. Identifikasi faktor resiko tuberkulosis multidrug resistant (TB-MDR). Maj Kedokt Indon. 2012;60(12):537-545.
Notoatmodjo, S. (2011). Kesehatan Masyarakat Ilmu dan Seni. Penerbit Rineka Cipta. Hal : 45
P. Farnia (2012). Susceptibility Testing: Multiplex -PCR, PCR-SSCP and PCR – ELISA Mycobacteriology Research Center (MRC). Iranian National Reference TB Laboratory, National Research Institute of Tuberculosis & Lung Disease (NRITLD). Protocol No:2. Halaman 21-49
Patel, D.M., Patel, S.D., Jaiswal, P., dan Brahmbhatt, K.J. (2012). Drug resistant Mycobacterium tuberculosis and new drug development. Int. J. Drug Dev. & Res. 4(2):76-91.
Pinto, L., and Menzies, D. (2011). Treatment of drug-resistant tuberculosis.
Infection and Drug Resistance. 4:129-135.
Pires, G.M., Folgosa, E., Nquobile, N., Gitta, S., and Cadir, N. (2014).
Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique. J Bras Pneumol. 40(2):142-147.
Ramaswamy, S. V., R.Reich,. Dou, L., Jasperse, X.Pan., A.Wanger., T. Quitugua., et al (2003). Single Nucleotide Polymorphisms in Genes Assosiated with Isoniazid Resistance in M.tuberculosis. Antimicroba: Agents Chemother.
Rattan, A., Kalia, A., and Ahmad, N. (1998). Multidrug-Resistant Mycobacterial tuberculosis : Molecular Perspective. Emerging Infectious Disease. Halaman 195-206.
Raizada, N., Sachdeva, K.S., and Chauhan, D.S. (2014). A multi-site validation in India of the Line Probe Assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens. PLoS One. 9(2).
Rifat M., Milton AH., and Hall J. (2014). Development of Multidrug Resistant Tuberculosis in Bangladesh: A Case-Control Study on Risk Factors. PLoS One. 9(8).
Rinanda, T. (2015). Kajian Molekuler Mekanisme Resistensi Mycobacterium Tuberculosis.Jurnal Kedokteran Syiah Kuala Volume. 15(3):162-167
Sarwani, D. (2012). Faktor resiko multidrug resistant tuberculosis (MDR-TB).
Jurnal Kesehatan Masyarakat. 8(1):60-66
Sharma, R., Yadav, R., Sharma, M., Saini, V., and Koushal,. (2014). Quality of life of multi drug resistant tuberculosis patients:a study of North India
Acta Medica Iranica. 52(6):448-453
Shim, T.S., and Jo, K.W. (2013). Medical treatment of pulmonary multidrug-resistant tuberculosis. Infect Chemother. 45(4):367-374.
Sihombing, H. (2011). Pola Resistensi Primer pada Penderita TB Paru Kategori I di RSUPH Adam Malik Medan. Tesis. Departemen Pulmonologi dan Ilmu Kedokteran Respirasi Fakultas Kedokteran Universitas Sumatera Utara. Halaman 48-50.
Sinaga, B.Y.M. (2013). Karakteristik penderita Multidrug Resistant Tuberculosis
yang mengikuti Programmatic Management of Drug-Resistant Tuberculosis di Rumah Sakit Umum Pusat H. Adam Malik Medan. J Respir Indo Vol. 33, No. 4 :221-229.
Sirait, N., Parwati, I., Dewi, N.S., dan Suraya, N. (2013). Validitas metode Polymerase Chain Reaction GeneXpert MTB/RIF pada bahan pemeriksaan sputum untuk mendiagnosis multidrug resistant tuberculosis.
MKB. 45(4):234-239.
Soepandi, P.Z. (2010). Diagnosis dan faktor yang mempengaruhi terjadinya MDR TB. Jurnal Tuberkulosis Indonesia. 7:16-9.
Sudjadi. (2008). Biotekhnologi Kesehatan .Yogyakarta. Penerbit Kanisius.27-45.
Suharmiati dan Maryani H. (2011). Analisis hubungan penggunaan obat FDC/kombipak pada penderita yang didiagnosis TB paru berdasarkan karakteristik. Buletin Penelitian Sistem Kesehatan. 14:167-173.
Susanty, E. (2015). Uji Diagnostik Genexpert MTB/RIF Di Rumah Sakit Umum Pusat Haji Adam Malik Medan. Tesis. Ilmu Kedokteran Tropis Universitas Sumatera Utara. Halaman 1-50.
Thristy, I. (2013). Analisa Aspergillus fumigatus Dengan Menggunakan Polymerase Chain Reaction (Pcr) Dan Kultur Pada Sputum Penderita Batuk Kronis. Tesis. Ilmu Biomedik Universitas Sumatera Utara. Halaman 40-45.
Ubyaan, R. (2012). Studi Pengaruh Mutasi gen rpoB pada kodon 513 ; analisis pada isolat papua. Prosiding Insinas.0195:1-5
Wijaya Made, D., Wirajana, I.N., dan Yowani, S.C. (2014). Amplifikasi dan Identifikasi Mutasi Pada fragmen 0,5 KB gen rpoB Isolat 134 B Isolat 134
Mycobacterium tuberculosis Multidrug Resistant dengan Metode Nested Polymerase Chain Reaction. Jurnal Kimia. 8(2):166-170.
Wijaya Made, D., Rusyanthini, E.P., Pradnyantini, D.G., Komalasari, K.T., dan Sunarti, L.P. (2014). Identifikasi mutasi gen rpoB pada Isolat
Mycobacterium tuberculosis Multidrug Resistant dengan Metode Nested Polymerase Chain Reaction. Jurnal Kimia. 8(2):1-4.
World Health Organization (2015). Multidrug-resistant tuberculosis 2015 update.
World Health Organization (2015). Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva, (WHO/HTM/TB/2014.11):77-94.
World Health Organization. (2013b). Defenition and reporting framework for tuberculosis-2013 revision.
World Health Organization. (2013c). The use of molecular line probe assay for detection of resistance to second-line anti-tuberculosis drug. Expert Group Meeting Report. Geneva.
World Health Organization. (2013d). Tuberculosis diagnostics Xpert MTB/RIF test. Available at: www.who.int/tb/features_archive/factsheet_xpert.pdf. Accesed August 16, 2014.
World Health Organization. (2014). Global tuberculosis report 2015. Geneva. Available at : http://www.tbonline.info/posts/2015/10/28/global-tuberculosis-report-2015/. Accesed December 5, 2016
Yao, C., Zhu, T., and Li, Y. (2010). Detection of rpoB, katG and inhA mutations in Mycobacterium tuberculosis in clinical isolates from Chonqing as determined by microarray. Clin Microbiol Infect. 16:1639-1643.
Yuan, X., Zhang, T., and Kawakami K,. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China. BMC Infectious Diseases. 2013;13(315).
Zhang, Y., and Yew, W.W. (2009). Mechanisms of drug resistance in
Mycobacterium tuberculosis. Int J Tuber Lung Dis. 13(11):1320–1330.
Zhao, Y., Xu, S., and Wang, L. (2012). National survey of drug resistant tuberculosis in China. N Engl J Med. 366:2161-2170.
Zhenling, C. (2014). Mutations in the embC-embA Intergenic Region Contribute to Mycobacterium tuberculosis Resistance to Ethambutol. Journal ASM.org. 58(11): 6837–6843.
